Cardiac Contractility Modulation in Patients With Chronic Heart Failure and the Various Forms of Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2018

Primary Completion Date

December 10, 2019

Study Completion Date

March 30, 2022

Conditions
Heart FailureAtrial FibrillationLeft Ventricular Ejection Fraction
Interventions
DEVICE

optimizer smart

The CCM implantation procedure was performed in the right precordial region of the chest (the right subclavian area). Two active fixation Ingevity leads (Boston Scientific) were advanced via the right subclavian vein into the right ventricle (RV) and actively fixed to the right ventricular septum for ventricular sensing and delivery of CCM signals.

Trial Locations (1)

121552

Alfiya Safiullina, Moscow

All Listed Sponsors
collaborator

Ministry of Health, Russian Federation

OTHER_GOV

lead

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

OTHER_GOV

NCT05550792 - Cardiac Contractility Modulation in Patients With Chronic Heart Failure and the Various Forms of Atrial Fibrillation | Biotech Hunter | Biotech Hunter